Emily Gavin
Acute Care · Saint Louis, MONPI 1831500503
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,958 of the $2,827 with a category attached, or 69.3%. 13 manufacturers reported payments, led by Solventum Corporation at 45.8% of the total. Reporting peaked in 2024 at $1,991 and has fallen 84.1% since, to $316 in 2025. Among acute care clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $50.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Solventum Corporation$1K
- Hydrofera LLC$371
- Takeda Pharmaceuticals U.S.A., Inc.$257
- Convatec Inc.$170
- Kerecis Limited$159
- KCI USA, Inc.$140
- plus $434 from 7 others
What the payments were for
- Travel & lodging$86931%
- Food & beverage$1,95869%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Solventum Corporation | 14 | $1,295 |
| Hydrofera LLC | 10 | $371 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $257 |
| Convatec Inc. | 2 | $170 |
| Kerecis Limited | 2 | $159 |
| KCI USA, Inc. | 3 | $140 |
| Integra Lifesciences Corporation | 6 | $110 |
| Johnson & Johnson | 1 | $100 |
| Polynovo North America LLC | 2 | $58 |
| Abbott | 1 | $57 |
| Smith+Nephew | 2 | $37 |
| Urgo Medical North America, LLC | 1 | $36 |
| Nxstage Medical, Inc. | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PREVENA$1,050
- Kerecis Omega3 Marigen$591
- HYDROFERA BLUE$150
- Kerecis Omega3 SurgiClose$148
- V.A.C. DERMATAC$103
- V.A.C. VERAFLO$103
- XARELTO$100
How this compares
$2,827 in reported general payments places this provider in the 90th percentile of 272 acute care providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 16 | $110 |
| Gabapentin | 11 | $90 |
| Cyclobenzaprine Hcl | 14 | $64 |
| Levetiracetam | 14 | $44 |
Paid to pharmacies, not to this prescriber.
Other acute care in Saint Louis
- Jennifer ReganSaint Louis$5K
- Kayla TourvilleSaint Louis$5K
- Christa SinkSaint Louis$5K
- Shalu LamaSaint Louis$3K
- Brittany ZellerSaint Louis$3K
- Molly HulsenSaint Louis$2K
- Patricia ClarkSaint Louis$2K
- Paula VaughnSaint Louis$2K
- Jennifer BurnsSaint Louis$2K
- Kamela Casey-BaggetteSaint Louis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.